The journal’s Editorial Office and Editorial Board are jointly issuing a resolution and removal of the Journal Notice linked to this article [], as well as an update to the original publication. Following concerns raised about the integrity of the peer-review, the Editorial Office has conducted a post-publication peer-review of this article. This process included the recruitment of a new independent reviewer and was supervised by an Editorial Board member to ensure full compliance with MDPI’s Editorial Process (https://www.mdpi.com/editorial_process).
As a result of this process, the Editorial Board member and the authors have agreed to remove Reviewer 1 report and upload the new one to the peer review record (https://www.mdpi.com/1422-0067/24/20/15215/review_report).
With this update, the Academic Editor is satisfied that the Editorial Process relating to this article has been completed as per MDPI’s Editorial Process policy. The Editorial Office would like to thank the authors for their collaboration during this process.
Reference
- Mora-Palazuelos, C.; Villegas-Mercado, C.E.; Avendaño-Félix, M.; Lizárraga-Verdugo, E.; Romero-Quintana, J.G.; López-Gutiérrez, J.; Beltrán-Ontiveros, S.; Bermúdez, M. The Role of ncRNAs in the Immune Dysregulation of Preeclampsia. Int. J. Mol. Sci. 2023, 24, 15215. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).